Study Name: Study of IMC-18F1 or Ramucirumab DP in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients
20 locations found
- ImClone Investigational Site
Location: New York, New York 10021
- ImClone Investigational Site
Location: Bronx, New York 10461
- ImClone Investigational Site
Location: Stony Brook, New York 11794
- ImClone Investigational Site
Location: Richmond, Virginia 23230
- ImClone Investigational Site
Location: Morgantown, West Virginia 26506
- ImClone Investigational Site
Location: Washington, North Carolina 27889
- ImClone Investigational Site
Location: Atlanta, Georgia 30322
- ImClone Investigational Site
Location: Augusta, Georgia 30912
- ImClone Investigational Site
Location: Jacksonville, Florida 32224
- ImClone Investigational Site
Location: Columbus, Ohio 43219
- ImClone Investigational Site
Location: Cincinnati, Ohio 45242
- ImClone Investigational Site
Location: Indianapolis, Indiana 46202
- ImClone Investigational Site
Location: Scottsdale, Arizona 85259
- ImClone Investigational Site
Location: Los Angeles, California 90033
- ImClone Investigational Site
Location: Chicago, Illinois 60611
- ImClone Investigational Site
Location: Baton Rouge, Louisiana 70809
- ImClone Investigational Site
Location: Dallas, Texas 75390
- ImClone Investigational Site
Location: San Antonio, Texas 78229
- ImClone Investigational Site
Location: Salt Lake City, Utah 84106
- ImClone Investigational Site
Location: Spokane, Washington 99208
|